UK markets closed

Envoy Medical, Inc. (COCH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.1100+0.0900 (+2.98%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 59.19M
Enterprise value 55.54M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)119.97
Price/book (mrq)N/A
Enterprise value/revenue 175.75
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-70.22%
S&P500 52-week change 326.36%
52-week high 311.7200
52-week low 30.7470
50-day moving average 34.8726
200-day moving average 34.4323

Share statistics

Avg vol (3-month) 3453.62k
Avg vol (10-day) 354.66k
Shares outstanding 519.6M
Implied shares outstanding 619.6M
Float 87.16M
% held by insiders 163.69%
% held by institutions 16.75%
Shares short (30 Apr 2024) 422.53k
Short ratio (30 Apr 2024) 40.19
Short % of float (30 Apr 2024) 40.31%
Short % of shares outstanding (30 Apr 2024) 40.11%
Shares short (prior month 28 Mar 2024) 442.53k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-8,301.70%

Management effectiveness

Return on assets (ttm)-202.73%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)297k
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)-24.40%
Gross profit (ttm)N/A
EBITDA -19.36M
Net income avi to common (ttm)-22.93M
Diluted EPS (ttm)-2.3800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.95M
Total cash per share (mrq)0.25
Total debt (mrq)5.36M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.11
Book value per share (mrq)-0.38

Cash flow statement

Operating cash flow (ttm)-20.49M
Levered free cash flow (ttm)-7.77M